Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 7:48 PM UTC
| NCT Number | NCT07205822 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | PHASE3 |
| Target Enrollment | 100 participants |
| Active Locations | 6 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | August 28, 2026 (19 hours ago) |
As of August 28, 2026: Clinical trial NCT07205822 is currently recruiting participants. This phase3 study for breast cancer is actively seeking new participants at 6 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07205822 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07205822 was last updated 19 hours ago (August 28, 2026). HelloStudys verifies this status automatically.